Lehavim, Israel

Angel Porgador

This inventor holds 8 USPTO granted patents and 9 published patent applications and 6 EPO patents. Top assignees: Ben-Gurion University of the Negev Research and Development Authority, Hadasit Medical Research Services and Development Ltd., The National Institute for Biotechnology in the Negev Ltd.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angel Porgador. Retrieved from https://idiyas.com/inventor/angel-porgador

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Lehavia, IL (2010)
  • Lehavim, IL (2013 - 2018)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Mind of Angel Porgador: A Pioneer in Modified Cell Research

Introduction

Angel Porgador, an accomplished inventor based in Lehavim, Israel, has made significant contributions to the field of biomedical research with a total of seven patents to his name. His innovative work primarily revolves around modified cells and their applications in treating debilitating conditions, such as amyotrophic lateral sclerosis (ALS).

Latest Patents

Porgador's latest patents demonstrate his expertise in developing cutting-edge medical technologies. One of his notable inventions is a patent for "Non-cytotoxic modified cells and use thereof." This invention encompasses modified cells that contain a transmembrane polypeptide with an extracellular target receptor-binding domain, a transmembrane domain, and an intracellular domain that does not transduce any signal. The methods he introduced in this patent allow for the induction or inhibition of signaling by a target receptor in a target cell through the interaction with these modified cells.

Another groundbreaking patent addresses diagnostic and therapeutic methods for amyotrophic lateral sclerosis (ALS). This invention provides a novel method for treating or delaying the onset of ALS by administering an agent that interferes with IgG-A2BG2 expression, function, or its interaction with CD16 in patients. These contributions have the potential to significantly influence ALS treatment strategies.

Career Highlights

Throughout his career, Angel Porgador has been associated with reputable research institutions, including the Ben-Gurion University of the Negev Research and Development Authority and Hadasit Medical Research Services and Development Ltd. His proficiency in the field and his dedication to research have established him as a leader in medical innovations.

Collaborations

Porgador's work has been further enriched by collaborations with esteemed professionals, such as Ofer Mandelboim and Yaakov Naparstek. These partnerships highlight the importance of teamwork in advancing research and technology in healthcare.

Conclusion

Angel Porgador's innovative contributions in the area of modified cells and treatments for ALS underline his significance as an inventor in the biomedical field. With several patents to his name, his work not only exemplifies creativity and scientific aptitude but also offers hope for advancements in medical therapies that could transform countless lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…